Abstract
Transgenesis has become a useful tool in effecting a complete or partial remodeling of the cardiac contractile apparatus. Although gene dosage effects were initially a concern, recent data showed that the heart is able to accommodate varying levels of transgenic over-expression without detectable ill effects. The present study was designed to test the limits of the transgenic paradigm in terms of the production of a cardiac phenotype due simply to the over-expression of a contractile protein. To this end, eight lines of mice which express an isoform of the essential myosin light chain 1 that is normally found in the adult ventricle (ELC1v) were generated. Overt phenotype was correlated both with the level of expression/protein replacement and copy number of the transgene. Two of the lines showed essentially complete replacement of the atrial isoform (ELC1a) with ELC1v. However, the phenotypes of the two lines differed dramatically. The line with the lower copy number (37 copies), and moderate over-expression (16 fold) showed no overt pathology while a line with very high copy number (94 copies) and extremely high levels of over-expression (27–50 fold) developed a significant atrial hypertrophy, dilation and cardiomyopathy. These data indicate that very high expression levels of a contractile protein can cause a cardiac pathology that is unrelated to its degree of replacement in the sarcomere and the unique role(s) it may assume in motor protein function.
Similar content being viewed by others
References
Adolph, E.A., Subramaniam, A., Cserjesi, P., Olson, E.N. and Robbins, J. (1993) Role of myocyte-specific enhancer-binding factor (MEF-2) in transcriptional regulation of the alpha-cardiac myosin heavy chain gene. J. Biol. Chem. 268, 5349–52.
Becker, K.D., Gottshall, K.R. and Chien, K.R. (1996) Strategies for studying cardiovascular phenotypes in genetically manipulated mice. Hypertension 3, 495–501.
Bernstein, S.I., O'Donnell, P.T. and Cripps, R.M. (1993) Molecular genetic analysis of muscle development, structure, and function in Drosophila. Int. Rev. Cytology 143, 63–152.
Field, L.J. (1993) Transgenic mice in cardiovascular research, Ann. Rev. Physiol. 55, 97–114.
Fyrberg, E. and Beall, C. (1990) Genetic approaches to myofibril form and function in Drosophila. Trends Genetics 6, 126–31.
Gardin, J.M., Siri, F.M., Kitsis, R.N., Edwards, J.G. and Leinwand, L.A. (1995) Echocardiographic assessment of left ventricular mass and systolic function in mice. Circ. Res. 76, 907–14.
Gulick, J., Hewett, T.E., Klevitsky, R., Buck, S., Moss, R.L. and Robbins, J. (1997) Transgenic remodeling of the regulatory myosin light chains in the mammalian heart. Circ. Res. 80, 655–64.
Hunter, J.J., Tanaka, N., Rockman, H.A., Ross, J.J. and Chien, K.R. (1995) Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice. J. Biol. Chem. 270, 23173–8.
Jones, W.K., Grupp, I.L., Doetschman, T., Grupp, G., Osinska, H., Hewett, T.E., Boivin, G., Gulick, J., Ng, W.A. and Robbins, J. (1996) Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart. J. Clin. Invest. 98, 1906–17.
Kadambi, V.J., Ponniah, S., Harrer, J.M., Hoit, B.D., Dorn, G.W.N., Walsh, R.A. and Kranias, E.G. (1996) Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. J. Clin. Invest. 97, 533–9.
Kelly, R. and Buckingham, M.E. (1997) Manipulating myosin light chain 2 isoforms in vivo. Circ. Res. 80, 751–3.
Koch, W.J., Milano, C.A. and Lefkowitz, R.J. (1996) Transgenic manipulation of myocardial G protein-coupled receptors and receptor kinases. Circ. Res. 78, 511–16.
McAuliffe, J.J., Gao, L. and Solaro, R.J. (1990) Changes in myofibrillar activation and troponin C Ca2. binding associated Transgenic remodeling of the heart 21 with troponin T isoform switching in developing rabbit heart. Cir. Res. 66, 1204–16.
McDonald, K.S., Field, L.J., Parmacek, M.S., Soonpaa, M., Leiden, J.M. and Moss, R.L. (1995) Length dependence of Ca2. sensitivity of tension in mouse cardiac myocytes expressing skeletal troponin C. J. Physiol. 483, 131–9.
Milano, C.A., Allen, L.F., Dolber, P.C., Johnson, T.D., Rockman, H.A., Bond, R.A. and Lefkowitz, R.J. (1995) Marked enhancement in myocardial function resulting from overexpression of a human beta-adrenergic receptor gene. J. Thoracic & Cardiovasc. Surgery 109, 236–41.
Milano, C.A., Allen, L.F., Rockman, H.A., Dolber, P.C., McMinn, T.R., Chien, K.R., Johnson, T.D., Bond, R.A. and Lefkowitz, R.J. (1994) Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. Science 264, 582–6.
Morano, I., Ritter, O., Bonz, A., Timek, T., Vahl, C.F. and Michel, G. (1995) Myosin light chain-actin interaction regulates cardiac contractility. Circ. Res. 76, 720–5.
Muthuchamy, M., Grupp, I.L., Grupp, G., O'toole, B.A., Kier, A.B., Boivin, G.P., Neumann, J. and Wieczorek, D.F. (1995) Molecular and physiological effects of overexpressing striated muscle beta-tropomyosin in the adult murine heart. J. Biol. Chem. 270, 30593–603.
Ng, W.A., Grupp, I.L., Subramaniam, A. and Robbins, J. (1991) Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ. Res. 68, 1742–50.
Palermo, J., Gulick, J., Colbert, M., Fewell, J. and Robbins, J. (1996) Transgenic remodeling of the contractile apparatus in the mammalian heart. Circ. Res. 78, 504–9.
Palermo, J., Gulick, J., Ng, W., Grupp, I.L., Grupp, G. and Robbins, J. (1995) Remodeling the mammalian heart using transgenesis. Cell. Mol. Biol. Res. 41, 501–9.
Rindt, H., Subramaniam, A. and Robbins, J. (1995) An in vivo analysis of transcriptional elements in the mouse alpha-myosin heavy chain gene promoter. Transgenic Res . 4, 397–405.
Robbins, J. (1976) The preparation and characterization of myosin complementary DNA. Ph. D. Thesis University of Connecticut at Storrs.
Robbins, J., Gulick, J., Sanchez, A., Howles, P. and Doetschman, T. (1990) Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro. J. Biol. Chem. 265, 11905–9.
Subramaniam, A., Jones, W.K., Gulick, J., Wert, S., Neumann, J. and Robbins, J. (1991) Tissue specific regulation of the á-myosin heavy chain gene promoter in transgenic mice. J. Biol. Chem. 266, 24216–20.
Sweeney, H.L. (1995) Function of the N terminus of the myosin essential light chain of vertebrate striated muscle. Biophys. J. 68, 112s-119s.
Tanaka, N., Dalton, N., Mao, L., Rockman, H.A., Peterson, K.L., Gottshall, K.R., Hunter, J.J., Chien, K.R. and Ross, J.J. (1996) Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation 94, 1109–17.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
James, J., Osinska, H., Hewett, T.E. et al. Transgenic Over-Expression of a Motor Protein at High Levels Results in Severe Cardiac Pathology. Transgenic Res 8, 9–22 (1999). https://doi.org/10.1023/A:1008894507995
Issue Date:
DOI: https://doi.org/10.1023/A:1008894507995